112 related articles for article (PubMed ID: 21512094)
1. Variation of breast vascular maps on dynamic contrast-enhanced MRI after primary chemotherapy of locally advanced breast cancer.
Martincich L; Bertotto I; Montemurro F; Ponzone R; Carbonaro LA; Regge D; Sardanelli F
AJR Am J Roentgenol; 2011 May; 196(5):1214-8. PubMed ID: 21512094
[TBL] [Abstract][Full Text] [Related]
2. Early changes in functional dynamic magnetic resonance imaging predict for pathologic response to neoadjuvant chemotherapy in primary breast cancer.
Ah-See ML; Makris A; Taylor NJ; Harrison M; Richman PI; Burcombe RJ; Stirling JJ; d'Arcy JA; Collins DJ; Pittam MR; Ravichandran D; Padhani AR
Clin Cancer Res; 2008 Oct; 14(20):6580-9. PubMed ID: 18927299
[TBL] [Abstract][Full Text] [Related]
3. Magnetic resonance imaging enhancement features before and after neoadjuvant chemotherapy in patients with breast cancer: a predictive value for responders.
Kang DK; Kim TH; Han TS; Kim KS; Yim H
J Comput Assist Tomogr; 2013; 37(3):432-9. PubMed ID: 23674017
[TBL] [Abstract][Full Text] [Related]
4. Predicting survival and early clinical response to primary chemotherapy for patients with locally advanced breast cancer using DCE-MRI.
Johansen R; Jensen LR; Rydland J; Goa PE; Kvistad KA; Bathen TF; Axelson DE; Lundgren S; Gribbestad IS
J Magn Reson Imaging; 2009 Jun; 29(6):1300-7. PubMed ID: 19472387
[TBL] [Abstract][Full Text] [Related]
5. A new algorithm for automatic vascular mapping of DCE-MRI of the breast: Clinical application of a potential new biomarker.
Vignati A; Giannini V; Carbonaro LA; Bertotto I; Martincich L; Sardanelli F; Regge D
Comput Methods Programs Biomed; 2014 Dec; 117(3):482-8. PubMed ID: 25262335
[TBL] [Abstract][Full Text] [Related]
6. Dynamic enhanced MRI predicts chemosensitivity in breast cancer patients.
Nagashima T; Sakakibara M; Nakamura R; Arai M; Kadowaki M; Kazama T; Nakatani Y; Koda K; Miyazaki M
Eur J Radiol; 2006 Nov; 60(2):270-4. PubMed ID: 16926079
[TBL] [Abstract][Full Text] [Related]
7. Role of dynamic contrast enhanced MRI in monitoring early response of locally advanced breast cancer to neoadjuvant chemotherapy.
Pickles MD; Lowry M; Manton DJ; Gibbs P; Turnbull LW
Breast Cancer Res Treat; 2005 May; 91(1):1-10. PubMed ID: 15868426
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the treatment response to neoadjuvant chemotherapy in locally advanced breast cancer using combined magnetic resonance vascular maps and apparent diffusion coefficient.
Wu LA; Chang RF; Huang CS; Lu YS; Chen HH; Chen JY; Chang YC
J Magn Reson Imaging; 2015 Nov; 42(5):1407-20. PubMed ID: 25875904
[TBL] [Abstract][Full Text] [Related]
9. [Value of dynamic contrast-enhanced MRI in assessment of early response to neoadjuvant chemotherapy in breast cancer].
Wang XH; Peng WJ; Xin C; Tan HN; Gu YJ; Tang F; Mao J
Zhonghua Zhong Liu Za Zhi; 2010 Jul; 32(7):539-43. PubMed ID: 21029700
[TBL] [Abstract][Full Text] [Related]
10. Role of Magnetic Resonance Imaging in the prediction of tumor response in patients with locally advanced breast cancer receiving neoadjuvant chemo-therapy.
Martincich L; Montemurro F; Cirillo S; Marra V; De Rosa G; Ponzone R; Aglietta M; Regge D
Radiol Med; 2003; 106(1-2):51-8. PubMed ID: 12951551
[TBL] [Abstract][Full Text] [Related]
11. Diffusion-weighted and dynamic contrast-enhanced MRI in evaluation of early treatment effects during neoadjuvant chemotherapy in breast cancer patients.
Jensen LR; Garzon B; Heldahl MG; Bathen TF; Lundgren S; Gribbestad IS
J Magn Reson Imaging; 2011 Nov; 34(5):1099-109. PubMed ID: 22002757
[TBL] [Abstract][Full Text] [Related]
12. Prediction of clinicopathologic response of breast cancer to primary chemotherapy at contrast-enhanced MR imaging: initial clinical results.
Padhani AR; Hayes C; Assersohn L; Powles T; Makris A; Suckling J; Leach MO; Husband JE
Radiology; 2006 May; 239(2):361-74. PubMed ID: 16543585
[TBL] [Abstract][Full Text] [Related]
13. MRI and conservative treatment of locally advanced breast cancer.
Julius T; Kemp SE; Kneeshaw PJ; Chaturvedi A; Drew PJ; Turnbull LW
Eur J Surg Oncol; 2005 Dec; 31(10):1129-34. PubMed ID: 15905068
[TBL] [Abstract][Full Text] [Related]
14. Invasive ductal breast carcinoma response to neoadjuvant chemotherapy: noninvasive monitoring with functional MR imaging pilot study.
Delille JP; Slanetz PJ; Yeh ED; Halpern EF; Kopans DB; Garrido L
Radiology; 2003 Jul; 228(1):63-9. PubMed ID: 12775851
[TBL] [Abstract][Full Text] [Related]
15. Monitoring breast cancer response to neoadjuvant systemic chemotherapy using parametric contrast-enhanced MRI: a pilot study.
Chou CP; Wu MT; Chang HT; Lo YS; Pan HB; Degani H; Furman-Haran E
Acad Radiol; 2007 May; 14(5):561-73. PubMed ID: 17434070
[TBL] [Abstract][Full Text] [Related]
16. Optical mammography using diffuse optical spectroscopy for monitoring tumor response to neoadjuvant chemotherapy in women with locally advanced breast cancer.
Schaafsma BE; van de Giessen M; Charehbili A; Smit VT; Kroep JR; Lelieveldt BP; Liefers GJ; Chan A; Löwik CW; Dijkstra J; van de Velde CJ; Wasser MN; Vahrmeijer AL
Clin Cancer Res; 2015 Feb; 21(3):577-84. PubMed ID: 25473002
[TBL] [Abstract][Full Text] [Related]
17. Monitoring neoadjuvant chemotherapy in breast cancer patients: improved MR assessment at 3 T?
Heldahl MG; Lundgren S; Jensen LR; Gribbestad IS; Bathen TF
J Magn Reson Imaging; 2011 Sep; 34(3):547-56. PubMed ID: 21761463
[TBL] [Abstract][Full Text] [Related]
18. Recurrence rates after DCE-MRI image guided planning for breast-conserving surgery following neoadjuvant chemotherapy for locally advanced breast cancer patients.
Garimella V; Qutob O; Fox JN; Long ED; Chaturvedi A; Turnbull LW; Drew PJ
Eur J Surg Oncol; 2007 Mar; 33(2):157-61. PubMed ID: 17085007
[TBL] [Abstract][Full Text] [Related]
19. Dynamic contrast-enhanced MRI texture analysis for pretreatment prediction of clinical and pathological response to neoadjuvant chemotherapy in patients with locally advanced breast cancer.
Teruel JR; Heldahl MG; Goa PE; Pickles M; Lundgren S; Bathen TF; Gibbs P
NMR Biomed; 2014 Aug; 27(8):887-96. PubMed ID: 24840393
[TBL] [Abstract][Full Text] [Related]
20. Relationship of clinical and pathologic response to neoadjuvant chemotherapy and outcome of locally advanced breast cancer.
Gajdos C; Tartter PI; Estabrook A; Gistrak MA; Jaffer S; Bleiweiss IJ
J Surg Oncol; 2002 May; 80(1):4-11. PubMed ID: 11967899
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]